Skip to content

Clinical trials

Observational Atrial Fibrillation trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Observational Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20131
20141
20171
20192
20202
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Unknown status2
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation3
Abbott Medical Devices2
Chinese University of Hong Kong2
Prince of Wales Hospital, Shatin, Hong Kong2
Bayer1
Boehringer Ingelheim1
Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation13
Stroke3
Brain Diseases1
Cardiac Conduction System Disease1
Cardiovascular Diseases1
Embolism1
Heart Diseases1
Renal Insufficiency, Chronic1
Tachycardia1
Venous Thromboembolism1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.